Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Methylprednisolone in Children with Chronic Rhinosinusitis
NCT01205984Phase 4Completed
- Sponsor
- Ondokuz Mayıs University
- Start
- Jul 2007
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Methylprednisolone Arm with Placebo Arm (2 arms). Primary endpoints: Mean change in total symptom score at 1 month and Mean change in coronal CT score at 1 month. Started Jul 2007; status: completed.
02
Drugs
methylprednisolone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01205984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205984.